SCHEMBL23085448

SCHEMBL23085448

CNC1CCc2ccc(C#CC3(O)COC3)cc2N(C)C1=O

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23075318 0.82 RIPK1 (0.64) RIPK1
SCHEMBL25585078 0.79 RIPK1 (0.41) RIPK1
SCHEMBL23075162 0.78 RIPK1 (0.43) RIPK1
SCHEMBL26493256 0.78 RIPK1 (0.76) RIPK1
SCHEMBL26493090 0.78 RIPK1 (0.76) RIPK1
SCHEMBL26493254 0.78 RIPK1 (0.76) RIPK1
SCHEMBL23075150 0.77 RIPK1 (0.80) RIPK1
SCHEMBL23066803 0.77 RIPK1 (0.80) RIPK1
SCHEMBL23066801 0.77 RIPK1 (0.80) RIPK1
SCHEMBL23066792 0.77 RIPK1 (0.77) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021046407-A1 RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2021-03-11 — — WO disclosed
Send feedback